SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " SJ " 2,785 found 🔀 AI-powered Shuffle
Rocket Lab Buys Satellite Operator Iridium in Bid to Challenge SpaceX
The deal would give Rocket Lab control over a satellite fleet and access to wireless resources it could use to compete with SpaceX.
Exclusive | Martin Marietta Strikes $13.5 Billion Deal for Limestone Supplier
Martin Marietta Strikes $13.5 Billion Deal for Limestone Supplier
Comcast Plans Company Split, Sending Shares Soaring 22%
The spinoff of NBCUniversal and Sky will separate the company’s connectivity business from its film, theme park and streaming operations.
Housing, groceries, and medical needs: Detroit’s Health Hubs helping to get kids to school
Since their launch in 2023, DPSCD’s Health Hubs have helped thousands of families and contributed to improving attendance for many students, according to the district.
Americans' pride in US history and democracy drops, and fewer are proud to be American, polls find
A new AP-NORC poll finds that Americans have grown less proud of the country’s history or the way its democracy works over the past several years
Sharks Sign Kesselring, How To Unlock His Potential?
The San Jose Sharks have signed Michael Kesselring. The Sharks signed the 26-year-old defenseman to a three-year, $13.5 million contract ($4.5 million AAV), buying up two of his UFA seasons. There were no trade protections. Kesselring was a pending RFA. The #SJSharks signed recently acquired 26 y/o RFA RD Michael Kesselring to 3 year $4.5M […] The post Sharks Sign Kesselring, How To Unlock His Potential? appeared first on San Jose Hockey Now.
BT, Verizon to Form International Joint Venture
The London-listed telecommunications operator said the 50:50 joint venture would serve more than 3,000 customers in around 180 countries.
America 250: L.A. Threads its Fabric
A decade ago, fashion newcomer Ari Jogiel turned a hat-making passion project into a one-stop-shop garment factory. At his namesake full-package company,
Rams news: QB battle, power rankings, top 100, power rankings
Some stories about the NFC West rival LA Rams from the last week for Arizona Cardinals fans to know.
Katy Perry cancels music festival performance at the last minute: 'They gave me no choice'
Katy Perry apologizes after her Werchter Boutique performance was canceled at the last minute, tells fans 'I am just as unhappy as you are.'
John West: Science and the American Founding
“Today, many people think that belief in a Creator is a subjective preference based on their personal faith. But that was not the view of America’s Founders.”
Hollywood celebrates Mel Brooks' 100th birthday
Mel Brooks' 100th birthday is being celebrated by friends, fans, and the whole of Hollywood.
Photos from start of Sunday's final Memorial Health Championship round
The final round of the Korn Ferry Tour's Memorial Health Championship was played on Sunday at Panther Creek. See the best images from the day.
Alan Ritchson's New Unusually Silent 'Motor City' Movie Described as 'John Wick Meets Reacher'
Alan Ritchson's latest movie is unusual because of its almost complete lack of dialogue.
Who do Scotland fans want as the next head coach?
The speculation has started, but who do Scotland fans want to replace Steve Clarke?
Airlines Are Installing New Luxury Seats, but No One Is Allowed to Sit in Them
Lie-flat seats in private pods face long waits for safety certifications, delaying debuts for carriers’ high-end offerings.
Hurricanes Acquire Rights to John Carlson
It had been a long day. Some teams were using all of their allotted time, even in the later rounds to make their draft decisions. Then came Carolina, and time had expired while the world waited for them to make pick number 192 in the Draft. What happened? Eric Tulsky and company smacked everyone in […]
Photo gallery | Day 3 of Memorial Health Championship at Panther Creek
See some of the most interesting images from the third round of the Korn Ferry Tour's Memorial Health Championship at Panther Creek from Saturday.
Washington Nationals vs Baltimore Orioles Game Thread
Follow along as the Nats look to snap their 4 game losing streak and get back to .500
Andy Burnham distanced himself from UK Prime Minister Starmer, but may be stuck with his policies
Burnham, the former mayor of Greater Manchester who was sworn into Parliament hours after Starmer announced his resignation on Monday, will be constrained by the platform the center-left Labour Party was elected on that decisively ended 14 years of Conservative rule in 2024.
Some paid the ultimate price to enact voting rights. Their survivors see America turning backward
It’s been six decades since the Voting Rights Act was enacted
Lawsuits filed against Pharr immigration-related business after filing unauthorized asylum claims
Two families have filed lawsuits against Pharr-based Ferrer Public Services, claiming the business filed unauthorized asylum applications that put their immigration status at risk.
Man with same name as US Sen. Dan Sullivan is eligible for Alaska's primary ballot, judge rules
An Alaska judge has ruled that a man with the same name and party affiliation as Alaska Republican U.S. Sen. Dan Sullivan is eligible to challenge the senator in the August primary
The impact of club sports on student experience in higher education
Authors: Ryan Savitz1, Divit Gupta2, Jared Ward3, Andrew Bjorkelo1 1Neumann University 2Conestoga High School 3Brigham Young University Corresponding Author: Ryan Savitz savitzr@neumann.edu …
General Atlantic Serves Up Djokovic Hire in Sports Push
The private-equity firm has already invested in a number of sports assets.
Colonial Market owner closes south Minneapolis location due to sharp drop in business following Metro Surge
Colonial Market owner Daniel Hernandez has closed the chain’s south Minneapolis location, which he said never recovered after the store’s employees and customers were targeted during Operation Metro Surge.
California’s Billionaire Tax Kicks Off a Democratic Civil War
The divisive proposal heads to the ballot after attempts to reach a compromise deal failed.
As San Joaquin County sees rise in rabid bats, public health says not to worry
Vance, an admirer of Richard Nixon, says Watergate would be 'a 12-hour news story' today
Vice President JD Vance says the Watergate scandal that brought down President Richard Nixon would have been a blip in today’s news cycle
Granger family pledges largest gift in history of UM-Health Sparrow
The Granger family has pledged the largest gift in University of Michigan Health-Sparrow history for a new behavioral health hospital.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Health Care Roundup: Market Talk
Find insight on GSK and Fresenius Medical Care in the latest Market Talks covering the Health Care sector.
How 12 ventures will improve health and food systems in Boston
Yes/Boston has announced its 12-member cohort through the UpLink Innovation Challenge to drive local innovation and transform food and health in Boston.
Chicago Cubs news
Dansby Swanson’s five-game hitting streak was capped Wednesday with a grand slam in the 10-3 win over the Mets
BlackBerry Sees New AI Opportunities as Embedded-Software Business Accelerates
BlackBerry lifted its fiscal 2027 outlook on higher first-quarter results, driven by embedded-software growth and expanding opportunities with artificial intelligence.
The Science Behind Venezuela’s Doublet Earthquake
The earthquakes that struck Venezuela were an uncommon but dangerous two-punch blow known as a doublet.
Germany’s Merck to Buy Bio-Techne for $11 Billion
Merck KGaA offered $73 a share in cash to buy Bio-Techne, representing a 24% premium to the U.S. lab-tools supplier’s closing price Wednesday.
ADUSA tapped a former Amazon exec to helm its business. What does this mean?
The grocery company’s nominee for the top role may raise some eyebrows given Amazon’s brick-and-mortar track record, but Claire Peters' appointment could be the key to further omnichannel growth.
Former Sparrow hospitals see improved finances 3 years after UM merger
The former Sparrow Health System was bleeding cash when it was swept up by the University of Michigan Health network three years ago. That's changed.
NASA rover finds record-breaking trove of complex organic molecules on Mars
Data from NASA’s Perseverance rover confirms the presence of macromolecular carbon on Mars – another potential piece of the puzzle in the search for life.
Prosus Investment Values Health Insurer Alan at $6.3 Billion
Prosus—the largest shareholder in Tencent Holdings and owner of food-delivery company Just Eat Takeaway—is investing €400 million in Alan.
Family towing business forced to start from scratch after theft
Thieves targeted a DeKalb County small business last Thursday, resulting in a devastating tow truck theft that impacts daily operations.
San José Postpones Plan to Double Downtown Parking Rates After Business Owner Uproar
Advocates for downtown businesses said the increase would hit the service industry hardest.
Anthropic Veterans’ Startup Seeks to Help Scientists Develop Their Own AI
Mirendil raises $200 million from Andreessen Horowitz and Kleiner Perkins to make AI that can do the job of an AI engineer.
Walmart gets bullish on advertising business with Vibe.co acquisition
The retailer plans to strengthen its higher-margin advertising division through a deal to acquire the CTV tech platform.
The SAVE America Act Is Finally Getting Its Moment
Plus, Mamdani-backed candidates win in New York, and how President Trump’s social-media posts complicated negotiations with Iran.
CEO of FNB Honored for Business Excellence, Leadership
Vincent Delie, chairman, president and CEO of F.N.B. Corp. and its largest subsidiary, First National Bank, received two national awards.
Marine surveys: Science and stewardship in action
Submitted by San Juan County.
German Business Confidence Edges Higher on Hopes Iran Tensions Ease
The Ifo business-climate index nevertheless remains at a subdued level, having plummeted after the outbreak of the war in Iran.
Israel’s Military Is Caught in a Political No Man’s Land in Lebanon
While Trump wants operations there to end, Israel’s public wants the military to keep fighting.
Exclusive | Walmart, in Biggest Deal in Two Years, Buys Advertising Tech Firm
The retail giant is purchasing Vibe.co, a company that enables advertising through connected TVs.
Microsoft Needs Its Own AI Strategy | AI & Business for June 23
Plus, tech job cuts, Sam Altman’s web of investments and Asia’s stock-market fever.
Jim Cramer Says McCormick “Is Still Reeling From Their Deal to Buy Unilever’s Food Business”
McCormick & Company, Incorporated (NYSE:MKC) was among the stocks Jim Cramer discussed as he said that the Iran peace negotiations could trigger an oil glut, cool inflation, and pull interest rates down. Cramer expects to hear a Unilever deal justification from the management, as he remarked: Also, on Thursday, we hear from McCormick. This is […]
Exclusive | Justice Department Unveils $6.5 Billion Healthcare Fraud Crackdown
Prosecutors are expected to charge around 450 defendants in alleged fraud spanning Medicaid and hospice care.
U.S. Business Activity Continued to Expand in June
U.S. business activity in the private sector continued to expand in June as brighter news out of the Middle East helped restore some confidence among U.S. businesses.
What I Saw at the Lincoln Memorial Reflecting Pool Monday Afternoon | WSJ Politics Newsletter for June 23
Plus, how President Trump’s war aims shifted, and ABC launches ads attacking the FCC.
Businesses In Europe, Asia See Costs Cooling On Peace Hopes
Eurozone businesses reported that their input costs rose at the slowest pace since the outbreak of the conflict, and they in turn increased their prices at a slower pace.
SJP celebrates her and Matthew Broderick's daughters' 17th birthday with never-before-seen photos
'Sex and the City' star Sarah Jessica Parker celebrates the 17th birthday of her and Matthew Broderick's twin daughters, Tabitha and Loretta, with never-before-seen photos.
Non-communicable diseases: how local coalitions can help
Place-based coalitions can help tackle NCDs. Community ownership is vital because prevention and behaviour change depend on trust and local legitimacy.
Health Brief: FDA signals reset in drug reviews
Plus: The data behind China’s biotech surge
iOS 27 Beta 2 Adds Inline Replies to iPhone-to-Android RCS Chats
With the second beta of iOS 27, Apple added support for replying to a specific message in an RCS conversation with an Android user. You can now long press on a message to get to the option to reply, and it works the same way that it does with iMessage. Apple added support for RCS in iOS 18, and has been improving it since then. iOS 26.5 added encryption for RCS messages sent between iPhone and Android users, and now more of the RCS features are being implemented.
UM Health - Sparrow officials break ground on new $60 million facility
The project expands UM Health-Sparrow Lansing's presence along Michigan Avenue while also furthering along the end of the St. Lawrence campus.
Fantasy Baseball Rest-of-Season Rankings: Scott Pianowski's updated risers and fallers as of June 22
The Supreme Court Is About to Decide Four Cases Defining Trump’s Power
Decisions involving immigration and power to fire government officials will help shape the president’s relationship with the court.
Moment of Science: “Antscan” project uses particle accelerator to map small insects in 3-D
It's the world of ants like you've never seen it before! Dan Smith shows how biology and particle physics are teaming up in the "Antscan" project. 🐜
Exclusive | Google Investing in ‘Backrooms’ Studio A24
The search giant is putting about $75 million into the studio as part of an artificial intelligence research partnership.
In Washington and Around the World, Alliances Are Rapidly Fraying | WSJ Politics Newsletter for June 22
Plus, more pool problems for Trump, and Jay Clayton remains in limbo over the post of director of national intelligence
‘Founder’ Is the New Brass Ring for Computer Science Grads
The share of employed 2025 CS graduates with the title doubled in a study of 20 universities with renowned tech programs.
Healthcare Investors GHO, CBC Weigh New Global Fund to Tap Into Asia’s Boom
Global Healthcare Opportunities and CBC Group discussed launching a new global fund after their merger, the firms’ heads said, as the healthcare investors move to tap into Asia’s rise as an innovation hub.
Opinion: We should restrict gambling marketing to protect youth
If we are going to permit online gaming and sports betting in our state, this is the least we can do to protect Michigan youth from misleading, coercive ads.
Opinion: We should restrict gambling marketing to protect youth
If we are going to permit online gaming and sports betting in our state, this is the least we can do to protect Michigan youth from misleading, coercive ads.
Exclusive | DHL Set to Transport Goods on New Wind-Powered Cargo Ships
The company’s freight forwarding arm plans to carry shipments across the Atlantic on specially built sailboats.
How to watch, what to know for 2026 Memorial Health Championship
Here's what to know and how to follow the Memorial Health Championship at Panther Creek Country Club this week.
Q+A: BizFed Brings in Waldman
The Los Angeles County Business Federation – commonly referred to in shorthand as BizFed – named longtime business advocate Stuart Waldman as its next
Tandy's Wales prepare for challenging summer of travel
Welsh domestic rugby might have finished at the end of May but there is very little rest for the Welsh national men's side this summer.
Thunder reportedly trading Aaron Wiggins to Hawks for picks in deal that provides tax relief for OKC
The Oklahoma City have traded guard Aaron Wiggins to the Atlanta Hawks in exchange for two second-round picks, ESPN’s Shams Charania reports.
NASCAR using its imagination with street races
Due to the success of Chicago and now the Naval Base Coronado street races, NASCAR is on a mission to find more locations that could shock the world.
Forum: One person’s journey in sports business
I spend a lot of time speaking to young people looking to get into the sports business, as well as people looking for a new opportunity mid-career.
The Would-Be Intelligence Chief Caught Between Trump and Congress
Jay Clayton is a versatile team player who has deftly navigated the Justice Department but is now in limbo regarding two jobs.
Back-to-School Shopping Starts…Now!
As shoppers spread out spending to manage their budgets, more retailers are promoting back-to-school deals with summer sales such as Amazon’s Prime Day.
Weekly Portland women’s sports wrap up (6/19)
Weekly Portland women’s sports wrap up (6/19). Presented by Rivermark Community Credit Union and Rebound Orthopedics and Neurosurgery.
Free community health event addresses gaps for Memphis families
Memphis families packed a community health and wellness event on Saturday, getting free screenings and support all under one roof.
Best Clint Eastwood Movies Ranked - and 1992 Western Takes Number 1 Spot
Clint Eastwood has made many memorable movies during his career, but one film stands out.
Jennifer Aniston joins 'Friends' in remembering James Burrows: 'He was a father figure to me'
Jennifer Aniston joined fellow 'Friends' stars in paying tribute to James Burrows, who directed the pilot episode of the hit sitcom. Burrows died on Friday at 85.
Jack Schlossberg Didn’t Expect a Congressional Campaign Like This
The Kennedy scion’s good looks and zany charm have earned him an online following. But can he win the votes?
Iran Can Now Sell Oil. How Fast Can It Ramp Up?
The Washington-Tehran deal allows Iranian oil shipments on the open market for the first time since 2018.
The Market’s AI Fanfare Is Running Into a Harsh Political Reality
Anthropic’s hopes for a blockbuster IPO could depend as much on the ballot box as on investors.
California’s Newsom, Under Federal Investigation, Leans Into Fight With Trump
The Democratic governor considering a presidential run has turned a Justice Department probe into a fundraising opportunity.
ABC30 sports director Stephen Hicks, reporter Gabe Ferris to depart
ABC30 is set to lose two of its on-air personalities this summer as sports director Stephen Hicks and reporter Gabe Ferris depart the Fresno station for new opportunities outside the Central Valley. Hicks announced Friday
Trump now says either Republican candidate would be a good pick in South Carolina's governor runoff
President Donald Trump has now endorsed both Republican candidates for governor in South Carolina
Exclusive | Charles Schwab Breaks into the Prediction Market Business
The brokerage is working with Cboe to offer yes-or-no contracts tied to the performance of the S&P 500 index.
Health Care Roundup: Market Talk
Find insight on Top Glove, BeOne Medicine and more in the latest Market Talks covering the health care sector.
Tech Investor Prosus’ Revenue Rises on Growth Across Businesses, Tencent
Core headline earnings are expected to increase between 19% to 28% reflecting strong revenue growth and profitability across its businesses, most notably Tencent.